Skip to main content

Table 5 Postoperative Outcomes

From: Right ventricular failure following left ventricular assist device implantation is associated with a preoperative pro-inflammatory response

  WBC < 10.5 K/μL (n = 362) WBC > 10.5 K/μL (n = 127) P Value
Total ICU LOS (mean days) 10.95 + 17.22 15.73 + 34.92 0.046
Total LOS (mean days) 26.06 + 20.15 30.86 + 35.58 0.064
Total Days Readmit (mean days) 38.14 + 54.11 31.94 + 45.47 0.248
Device Infection 95 (26.2%) 26 (20.5%) 0.195
Device Exchange Infection 21 (5.8%) 7 (5.5%) 0.904
Late AV Intervention 5 (1.4%) 1 (0.8%) 0.601
Stroke 94 (26.0%) 32 (25.2%) 0.864
Hemolysis 87 (24.0%) 28 (22.0%) 0.650
Postop Dialysis/CVVH 12 (3.3%) 11 (8.7%) 0.014
Postop Perm Dialysis 6 (1.7%) 3 (2.4%) 0.611
LVAD Death 107 (29.6%) 41 (32.3%) 0.565
Transplant 132 (36.5%) 42 (33.1%) 0.492
Operative Mortality 16 (4.4%) 8 (6.3%) 0.399
RV Failure 21 (5.8%) 17 (13.4%) 0.006
RVAD 16 (4.4%) 14 (11.0%) 0.008
Duration of RVAD (median) 17.0 (IQR = 18.0) 20.50 (IQR = 74.0) 0.452
Nitric Oxide Use 356 (98.3%) 125 (98.4%) 0.950
Nitric Duration (median days) 2.0 (IQR = 2.0) 2.0 (IQR = 2.0) 0.514
  1. Hospital stay times are expressed as mean + standard deviation. Duration of RVAD and nitric oxide use is expressed as median with interquartile range